
    
      The objectives of the study are 1) to compare the clinical efficacy of lidocaine and
      tetracaine cream 7%/7% with placebo cream in the treatment of neuropathic pain associated
      with postherpetic neuralgia (PHN) and 2) to monitor the nature and frequency of adverse
      events following a single, 60-minute application of lidocaine and tetracaine cream 7%/7% and
      placebo cream.
    
  